MISSIONPHARMA A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About MISSIONPHARMA A/S
MISSIONPHARMA A/S (CVR number: 26902398K) is a company from ALLERØD. The company reported a net sales of 928.8 mDKK in 2023, demonstrating a growth of 0.5 % compared to the previous year. The operating profit percentage was at 16.3 % (EBIT: 151.3 mDKK), while net earnings were 119.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 30.8 %, which can be considered excellent and Return on Equity (ROE) was 35.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 79.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. MISSIONPHARMA A/S's liquidity measured by quick ratio was 4.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 776.98 | 731.47 | 693.96 | 924.32 | 928.80 |
Gross profit | 81.53 | 171.93 | 122.25 | 229.34 | 219.96 |
EBIT | 81.53 | 171.93 | 71.63 | 159.60 | 151.34 |
Net earnings | 22.24 | 83.61 | 57.98 | 119.26 | 119.75 |
Shareholders equity total | 263.21 | 332.43 | 312.81 | 351.07 | 320.52 |
Balance sheet total (assets) | 380.97 | 427.21 | 428.52 | 550.15 | 470.29 |
Net debt | -8.24 | -25.04 | -29.07 | ||
Profitability | |||||
EBIT-% | 10.5 % | 23.5 % | 10.3 % | 17.3 % | 16.3 % |
ROA | 21.1 % | 42.5 % | 17.4 % | 33.4 % | 30.8 % |
ROE | 8.3 % | 28.1 % | 18.0 % | 36.0 % | 35.8 % |
ROI | 21.1 % | 42.5 % | 20.1 % | 48.7 % | 45.4 % |
Economic value added (EVA) | 67.98 | 158.70 | 39.10 | 111.48 | 101.27 |
Solvency | |||||
Equity ratio | 100.0 % | 100.0 % | 79.3 % | 77.5 % | 79.4 % |
Gearing | 0.3 % | 1.5 % | |||
Relative net indebtedness % | 15.4 % | 18.8 % | 12.5 % | ||
Liquidity | |||||
Quick ratio | 4.2 | 4.5 | 4.6 | ||
Current ratio | 3.3 | 2.6 | 3.0 | ||
Cash and cash equivalents | 9.10 | 25.04 | 33.77 | ||
Capital use efficiency | |||||
Trade debtors turnover (days) | 18.8 | 24.6 | 22.7 | ||
Net working capital % | 37.1 % | 33.5 % | 30.0 % | ||
Credit risk | |||||
Credit rating | AAA | AAA | AAA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.